Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jan;24(1):140-143.
doi: 10.1002/lt.24838.

Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient

Behnam Saberi  1 , James P Hamilton  1 , Christine M Durand  2 , Zhiping Li  1 , Benjamin Philosophe  3 , Andrew M Cameron  3 , Mark S Sulkowski  2 , Ahmet Gurakar  1
Affiliations
Case Reports

Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient

Behnam Saberi et al. Liver Transpl. 2018 Jan.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
(A) Pre- and post-LT trend of ALP, AST, and ALT (IU/L) in the recipient. Note that the DAA regimen was started 25 days following LT. (B) Pre- and post-LT trend of T.bili (mg/dL) in the recipient. Note that the DAA regimen was started 25 days following LT.
See this image and copyright information in PMC

Comment in

References

    1. Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, et al. OPTN/SRTR 2015 Annual Data Report: Liver. Am J Transplant 2017;17(suppl 1):174–251. - PubMed
    1. Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, et al. The American Society of transplantation consensus conference on the use of hepatitis C viremic donors in solid organ transplantation. Am J Transplant 2017;17:2790–2802. - PubMed
    1. Northup PG, Argo CK, Nguyen DT, McBride MA, Kumer SC, Schmitt TM, Pruett TL. Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int 2010;23: 1038–1044. - PubMed
    1. Abdelqader A, Kabacam G, Woreta TA, Hamilton JP, Luu H, Al Khalloufi K, et al. Pre-versus posttransplant treatment of hepatitis C virus with direct-acting antivirals in liver transplant recipients: more issues to be solved. Exp Clin Transplant 2017;15:1–5. - PubMed
    1. AASLD/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 2015; 62:932–954. - PubMed

MeSH terms